SABCS 2021: Zooming in on Breast Cancer Response to Immunotherapy at the Single-cell Level
Triple-negative breast cancer (TNBC) is aggressive, with high risk of metastasis and recurrence, and is challenging to treat due to a lack of effective targeted therapies. However, a higher...